U.S. flag

An official website of the United States government

GTR Home > Genes

SLC34A1 solute carrier family 34 member 1

Gene ID: 6569, updated on 23-Mar-2024
Gene type: protein coding
Also known as: NPT2; FRTS2; SLC11; HCINF2; NAPI-3; NPTIIa; NPHLOP1; SLC17A2

Summary

Enables sodium:phosphate symporter activity. Involved in several processes, including phosphate ion homeostasis; phosphate ion transport; and response to lead ion. Located in several cellular components, including apical plasma membrane; mitotic spindle; and nuclear speck. Implicated in several diseases, including Fanconi syndrome (multiple); chronic kidney disease; hereditary hypophosphatemic rickets with hypercalciuria; hypophosphatemic nephrolithiasis/osteoporosis 1; and nephrolithiasis. [provided by Alliance of Genome Resources, Apr 2022]

Associated conditions

See all available tests in GTR for this gene

DescriptionTests
A genome-wide association study of nephrolithiasis in the Japanese population identifies novel susceptible Loci at 5q35.3, 7p14.3, and 13q14.1.
GeneReviews: Not available
Fanconi renotubular syndrome 2
MedGen: C3150652OMIM: 613388GeneReviews: Not available
See labs
Genetic associations for activated partial thromboplastin time and prothrombin time, their gene expression profiles, and risk of coronary artery disease.
GeneReviews: Not available
Hypercalcemia, infantile, 2
MedGen: C4310473OMIM: 616963GeneReviews: Not available
See labs
Hypophosphatemic nephrolithiasis/osteoporosis 1
MedGen: C2676786OMIM: 612286GeneReviews: Not available
See labs
Meta-analysis of genome-wide association studies identifies six new Loci for serum calcium concentrations.
GeneReviews: Not available
New loci associated with kidney function and chronic kidney disease.
GeneReviews: Not available

Genomic context

Location:
5q35.3
Sequence:
Chromosome: 5; NC_000005.10 (177384434..177398848)
Total number of exons:
14

Links

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.